Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus
International Journal of Nephrology and Renovascular Disease | Jan 22, 2018
Most read this week